Syndax Pharmaceuticals Statistics

Total Valuation

SNDX has a market cap or net worth of $1.06 billion. The enterprise value is $896.63 million.

Market Cap	1.06B
Enterprise Value	896.63M

Important Dates

The last earnings date was Monday, March 3, 2025, before market open.

Earnings Date	Mar 3, 2025
Ex-Dividend Date	n/a

Share Statistics

SNDX has 86.02 million shares outstanding. The number of shares has increased by 21.67% in one year.

Current Share Class	86.02M
Shares Outstanding	86.02M
Shares Change (YoY)	+21.67%
Shares Change (QoQ)	+0.42%
Owned by Insiders (%)	0.38%
Owned by Institutions (%)	102.77%
Float	77.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	47.66
Forward PS	11.53
PB Ratio	3.92
P/TBV Ratio	3.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	37.86
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.82, with a Debt / Equity ratio of 1.20.

Current Ratio	5.82
Quick Ratio	5.76
Debt / Equity	1.20
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-68.91

Financial Efficiency

Return on equity (ROE) is -75.69% and return on invested capital (ROIC) is -35.69%.

Return on Equity (ROE)	-75.69%
Return on Assets (ROA)	-31.74%
Return on Invested Capital (ROIC)	-35.69%
Return on Capital Employed (ROCE)	-54.67%
Revenue Per Employee	$87,704
Profits Per Employee	-$1.18M
Employee Count	270
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.87% in the last 52 weeks. The beta is 0.92, so SNDX's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	-42.87%
50-Day Moving Average	14.26
200-Day Moving Average	17.55
Relative Strength Index (RSI)	43.83
Average Volume (20 Days)	1,779,642

Short Selling Information

The latest short interest is 18.82 million, so 21.88% of the outstanding shares have been sold short.

Short Interest	18.82M
Short Previous Month	19.20M
Short % of Shares Out	21.88%
Short % of Float	24.39%
Short Ratio (days to cover)	8.64

Income Statement

In the last 12 months, SNDX had revenue of $23.68 million and -$318.76 million in losses. Loss per share was -$3.72.

Revenue	23.68M
Gross Profit	-218.79M
Operating Income	-339.67M
Pretax Income	-264.08M
Net Income	-318.76M
EBITDA	-339.66M
EBIT	-339.67M
Loss Per Share	-$3.72

Full Income Statement

Balance Sheet

The company has $582.91 million in cash and $345.74 million in debt, giving a net cash position of $237.17 million or $2.76 per share.

Cash & Cash Equivalents	582.91M
Total Debt	345.74M
Net Cash	237.17M
Net Cash Per Share	$2.76
Equity (Book Value)	288.12M
Book Value Per Share	3.36
Working Capital	499.51M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-274.90M
Capital Expenditures	n/a
Free Cash Flow	-274.90M
FCF Per Share	-$3.20

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,434.43%
Pretax Margin	-1,346.11%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SNDX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.67%
Shareholder Yield	-21.67%
Earnings Yield	-28.11%
FCF Yield	-24.25%

Dividend Details

Analyst Forecast

The average price target for SNDX is $36.20, which is 193.47% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$36.20
Price Target Difference	193.47%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	94.08%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SNDX has an Altman Z-Score of -0.68 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.68
Piotroski F-Score	1